Brad Barnett
Direttore Tecnico/Scientifico/R&S presso COGENT BIOSCIENCES, INC.
Posizioni attive di Brad Barnett
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| COGENT BIOSCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | - | - |
Storia della carriera di Brad Barnett
Precedenti posizioni note di Brad Barnett
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ARRAY TECHNOLOGIES, INC. | Corporate Officer/Principal | 01/03/2015 | 01/08/2019 |
Formazione di Brad Barnett
| The University of Colorado | Masters Business Admin |
| Colorado State University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Masters Business Admin | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| COGENT BIOSCIENCES, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
- Borsa valori
- Insiders
- Brad Barnett
- Esperienza
